Sixth Ventracor device implanted
Thursday, 24 June, 2004
The sixth patient in Ventracor's (ASX:VCR) pilot trial has been implanted with the company's 'VentrAssist' left ventricular assistance device at The Alfred hospital in Melbourne.
Up to 10 implants are expected to be conducted for the trial.
Chief Medical Investigators, Professor Don Esmore and Professor David Kaye, said the operation had gone smoothly and the patient, who was gravely ill and suffering congestive heart failure, was now making a good recovery.
“The VentrAssist left ventricular assist system is performing as expected,” said Professor Esmore.
Three patients implanted with VentrAssist have reached nearly 12 months, 10 months and six months since their implants. Two other patients have passed away.
Ventracor has said it also plans to begin its clinical trial program for European CE Mark approval in mid-2004.
At time or writing Ventracor's shares were up 6 cents to $1.52.
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
Life expectancy gains are slowing, study finds
Life expectancy at birth in the world's longest-living populations has increased by an...
Towards safer epilepsy treatment for pregnant women
New research conducted in organoids is expected to provide pregnant women with epilepsy safer...